セリアック病治療の世界市場レポート 2025年

セリアック病治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.6%で、9億6,000万米ドルに成長します。予測期間中の成長は、セリアック病の世界的な有病率の上昇、認知度と診断率の向上、新規治療法の臨床試験の進行、グルテンフリーの代替品に対する需要の高まり、希少疾病に対する規制当局の支援策、ヘルスケア支出の増加など、いくつかの要因に起因すると考えられます。予測期間における主な動向としては、新規の非食事療法の採用、酵素補助食品の発展、個別化医療へのアプローチ、ペプチドベース免疫療法の開発、診断ツールの改善、臨床試験の進展などが挙げられます。

糖尿病の有病率の増加は、今後数年間におけるセリアック病治療市場の拡大を牽引すると予想されます。糖尿病は、血糖値を適切に調節できない体質を特徴とする慢性疾患です。この糖尿病有病率の増加は、糖尿病とセリアック病の間で食事管理のニーズが重複していることと関連しています。セリアック病治療は、グルテンフリーの食事を促進することで糖尿病患者をサポートし、消化器系の健康と栄養吸収を高め、血糖コントロールの改善を助けます。例えば、2024年6月、英国の政府機関である国民保健サービス（National Health Service）は、2023年に一般開業医に登録された約361万5,330人が非糖尿病性高血糖症または糖尿病予備軍と診断されたと報告し、これは2022年の306万5,825例から18％増加したことを反映しています。このように、糖尿病の有病率の増加がセリアック病治療市場を押し上げています。

セリアック病治療市場の主要企業は、グルテンに対する免疫反応を阻害し、治療のアドヒアランスを高め、制限的なグルテン除去食に代わる選択肢を提供するために、低分子薬などの革新的な経口療法の開発を優先しています。低分子治療薬は、病気の原因となるタンパク質や酵素を標的に、細胞に浸透できる小型の薬物です。例えば、2025年2月、米国のバイオテクノロジー企業Immunic Inc.は、内因性グルカゴン様ペプチド-1（GLP-1）レベルを上昇させる低分子治療薬IMU-856を発表しました。この治療は、セリアック病患者の腸管バリアの完全性を改善し、栄養吸収を高め、症状を軽減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のセリアック病治療のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のセリアック病治療市場：成長率分析
• 世界のセリアック病治療市場の実績：規模と成長、2019～2024年
• 世界のセリアック病治療市場の予測：規模と成長、2024～2029年、2034年
• 世界のセリアック病治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のセリアック病治療市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ビタミン・ミネラル
• グルテン分解酵素
• 対症療法
• その他
• 世界のセリアック病治療市場：症状別、実績と予測、2019～2024年、2024～2029年、2034年
• 腹部膨満
• 下痢
• 食欲不振
• 膨満感
• 腸内ガス
• 疲労感
• 世界のセリアック病治療市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 血清学的検査
• 遺伝子検査
• 生検
• 世界のセリアック病治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 研究センター
• クリニック
• その他
• 世界のセリアック病治療市場：ビタミン・ミネラルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 鉄サプリメント
• カルシウムサプリメント
• ビタミンD
• ビタミンB12
• マルチビタミン
• 世界のセリアック病治療市場：グルテン分解酵素のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• エンドペプチダーゼ
• エキソペプチダーゼ
• 複合酵素製剤
• 世界のセリアック病治療市場：対症療法のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 下痢止め薬
• 抗うつ薬
• 抗炎症薬
• 免疫抑制剤
• 世界のセリアック病治療市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プロバイオティクス
• 免疫療法
• 幹細胞療法
• 実験的治療法

第7章 地域別・国別分析

• 世界のセリアック病治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のセリアック病治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• セリアック病治療市場：競合情勢
• セリアック病治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Takeda Pharmaceuticals Company Ltd.
• Amgen Inc.
• General Mills Inc.
• Viatris Inc.
• Teva Pharmaceutical Inc.
• Nestle Health Science
• Hikma Pharmaceuticals PLC
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals Inc.
• Glenmark Pharmaceuticals Company Ltd.
• West-Ward Pharmaceuticals Company Ltd
• Innovate Biopharmaceutical
• Acto Biosciences
• ImmunogenX

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• セリアック病治療市場2029年：新たな機会を提供する国
• セリアック病治療市場2029年：新たな機会を提供するセグメント
• セリアック病治療市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Celiac disease treatment focuses on managing the autoimmune reaction to gluten, which damages the small intestine and impairs nutrient absorption. The primary approach is a strict gluten-free diet, which eliminates foods and products containing wheat, barley, rye, and other gluten-containing grains. This treatment reduces symptoms, heals the small intestine lining, and prevents long-term health complications.

The main types of treatment for celiac disease include vitamins and minerals, gluten-degrading enzymes, symptomatic treatments, and other approaches. Vitamins and minerals are essential micronutrients that support key bodily functions, such as immune response, energy production, and bone health. Enzyme therapies address symptoms such as distension, diarrhea, anorexia, bloating, gas, and fatigue. Diagnostic methods for celiac disease include serological tests, genetic testing, and intestinal biopsy. These treatments and diagnostic services are provided through various distribution channels, including hospitals, research centers, clinics, and others.

The Business Research Company that provides celiac disease treatment market statistics, including the celiac disease treatment industry global market size, regional shares, competitors with the celiac disease treatment market share, detailed celiac disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the celiac disease treatment industry. This celiac disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The celiac disease treatment market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to several factors, including the rising prevalence of celiac disease, increased awareness and diagnosis rates, a growing demand for non-dietary treatment options, a strong pipeline of innovative therapies, supportive regulatory initiatives, and higher investment from pharmaceutical companies.

The celiac disease treatment market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth during the forecast period can be attributed to several factors, including the rising global prevalence of celiac disease, increasing awareness and diagnosis rates, ongoing clinical trials for novel treatments, growing demand for gluten-free alternatives, supportive regulatory initiatives for orphan diseases, and rising healthcare expenditure. Key trends in the forecast period include the adoption of novel non-dietary therapies, advancements in enzyme supplements, personalized medicine approaches, the development of peptide-based immunotherapies, improvements in diagnostic tools, and progress in clinical trials.

The growing prevalence of diabetes is anticipated to drive the expansion of the celiac disease treatment market in the coming years. Diabetes is a chronic condition characterized by the body's inability to properly regulate blood glucose levels. This rise in diabetes prevalence is linked to overlapping dietary management needs between diabetes and celiac disease, as both require careful regulation of food intake to manage symptoms and prevent complications. Celiac disease treatments support individuals with diabetes by promoting a gluten-free diet, which enhances digestive health and nutrient absorption, aiding in improved blood sugar control. For instance, in June 2024, the National Health Service, a UK-based government agency, reported that approximately 3,615,330 individuals registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% increase from 3,065,825 cases in 2022. Thus, the increasing prevalence of diabetes is boosting the celiac disease treatment market.

Leading companies in the celiac disease treatment market are prioritizing the development of innovative oral therapies, such as small molecule drugs, to block immune responses to gluten, enhance treatment adherence, and provide alternatives to restrictive gluten-free diets. Small molecule therapies are compact drugs capable of penetrating cells to target proteins or enzymes that cause disease. For example, in February 2025, Immunic Inc., a US-based biotech firm, introduced IMU-856, a small molecule therapy that elevates endogenous glucagon-like peptide-1 (GLP-1) levels. This treatment improves the integrity of the intestinal barrier in patients with celiac disease, enhances nutrient absorption, and reduces symptoms-all without suppressing immune function.

In October 2022, Takeda Pharmaceutical Company Limited, a pharmaceutical company based in Japan, formed a partnership with Zedira GmbH and Dr. Falk Pharma to develop TAK-227 (ZED1227), an oral treatment for celiac disease. This therapy is designed to target intestinal inflammation and promote mucosal healing, representing a promising new option for patients. Zedira GmbH is a German biotech firm specializing in therapies for celiac disease and other transglutaminase-related conditions. Dr. Falk Pharma, also based in Germany, focuses on pharmaceutical solutions for gastrointestinal disorders.

Major players in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestle Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX.

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in celiac disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the celiac disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The celiac disease treatment market consists of sales of gluten-free food products, vitamin D, Vitamin B12, and folic acid supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Celiac Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on celiac disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for celiac disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The celiac disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Vitamins And Minerals; Gluten Degrading Enzymes; Symptomatic Treatment; Other Treatments
• 2) By Enzyme Type: Distension; Diarrhoea; Anorexia; Bloating; Gas; Fatigue
• 3) By Diagnosis: Serological Tests; Genetic Testing; Biopsy
• 4) By Distribution Channel: Hospitals; Research Centres; Clinics; Other Distribution Channels
• Subsegments:
• 1) By Vitamins and Minerals: Iron Supplements; Calcium Supplements; Vitamin D; Vitamin B12; Multivitamins
• 2) By Gluten Degrading Enzymes: Endopeptidases; Exopeptidases; Combination Enzyme Formulations
• 3) By Symptomatic Treatment: Antidiarrheal Medications; Antidepressants; Anti-inflammatory Drugs; Immunosuppressive Agents
• 4) By Other Treatments: Probiotics; Immunotherapy; Stem Cell Therapy; Experimental Therapies
• Companies Mentioned: Pfizer Inc.; Johnson And Johnson; F. Hoffmann-La Roche Ltd.; Merck And Co. Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Celiac Disease Treatment Market Characteristics

3. Celiac Disease Treatment Market Trends And Strategies

4. Celiac Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Celiac Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Celiac Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Celiac Disease Treatment Market Growth Rate Analysis
• 5.4. Global Celiac Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Celiac Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Celiac Disease Treatment Total Addressable Market (TAM)

6. Celiac Disease Treatment Market Segmentation

• 6.1. Global Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamins And Minerals
• Gluten Degrading Enzymes
• Symptomatic Treatment
• Other Treatments
• 6.2. Global Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Distension
• Diarrhea
• Anorexia
• Bloating
• Gas
• Fatigue
• 6.3. Global Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serological Tests
• Genetic Testing
• Biopsy
• 6.4. Global Celiac Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Centers
• Clinics
• Other Distribution Channels
• 6.5. Global Celiac Disease Treatment Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iron Supplements
• Calcium Supplements
• Vitamin D
• Vitamin B12
• Multivitamins
• 6.6. Global Celiac Disease Treatment Market, Sub-Segmentation Of Gluten Degrading Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endopeptidases
• Exopeptidases
• Combination Enzyme Formulations
• 6.7. Global Celiac Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antidiarrheal Medications
• Antidepressants
• Anti-inflammatory Drugs
• Immunosuppressive Agents
• 6.8. Global Celiac Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Probiotics
• Immunotherapy
• Stem Cell Therapy
• Experimental Therapies

7. Celiac Disease Treatment Market Regional And Country Analysis

• 7.1. Global Celiac Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Celiac Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Celiac Disease Treatment Market

• 8.1. Asia-Pacific Celiac Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Celiac Disease Treatment Market

• 9.1. China Celiac Disease Treatment Market Overview
• 9.2. China Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Celiac Disease Treatment Market

• 10.1. India Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Celiac Disease Treatment Market

• 11.1. Japan Celiac Disease Treatment Market Overview
• 11.2. Japan Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Celiac Disease Treatment Market

• 12.1. Australia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Celiac Disease Treatment Market

• 13.1. Indonesia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Celiac Disease Treatment Market

• 14.1. South Korea Celiac Disease Treatment Market Overview
• 14.2. South Korea Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Celiac Disease Treatment Market

• 15.1. Western Europe Celiac Disease Treatment Market Overview
• 15.2. Western Europe Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Celiac Disease Treatment Market

• 16.1. UK Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Celiac Disease Treatment Market

• 17.1. Germany Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Celiac Disease Treatment Market

• 18.1. France Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Celiac Disease Treatment Market

• 19.1. Italy Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Celiac Disease Treatment Market

• 20.1. Spain Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Celiac Disease Treatment Market

• 21.1. Eastern Europe Celiac Disease Treatment Market Overview
• 21.2. Eastern Europe Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Celiac Disease Treatment Market

• 22.1. Russia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Celiac Disease Treatment Market

• 23.1. North America Celiac Disease Treatment Market Overview
• 23.2. North America Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Celiac Disease Treatment Market

• 24.1. USA Celiac Disease Treatment Market Overview
• 24.2. USA Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Celiac Disease Treatment Market

• 25.1. Canada Celiac Disease Treatment Market Overview
• 25.2. Canada Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Celiac Disease Treatment Market

• 26.1. South America Celiac Disease Treatment Market Overview
• 26.2. South America Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Celiac Disease Treatment Market

• 27.1. Brazil Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Celiac Disease Treatment Market

• 28.1. Middle East Celiac Disease Treatment Market Overview
• 28.2. Middle East Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Celiac Disease Treatment Market

• 29.1. Africa Celiac Disease Treatment Market Overview
• 29.2. Africa Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Celiac Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Celiac Disease Treatment Market Competitive Landscape
• 30.2. Celiac Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Celiac Disease Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Takeda Pharmaceuticals Company Ltd.
• 31.3. Amgen Inc.
• 31.4. General Mills Inc.
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceutical Inc.
• 31.7. Nestle Health Science
• 31.8. Hikma Pharmaceuticals PLC
• 31.9. Amneal Pharmaceuticals LLC
• 31.10. Zydus Pharmaceuticals Inc.
• 31.11. Glenmark Pharmaceuticals Company Ltd.
• 31.12. West-Ward Pharmaceuticals Company Ltd
• 31.13. Innovate Biopharmaceutical
• 31.14. Acto Biosciences
• 31.15. ImmunogenX

32. Global Celiac Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Celiac Disease Treatment Market

34. Recent Developments In The Celiac Disease Treatment Market

35. Celiac Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Celiac Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Celiac Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Celiac Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer